Published in Nucleic Acids Res on August 01, 2002
Homogeneous detection of unamplified genomic DNA sequences based on colorimetric scatter of gold nanoparticle probes. Nat Biotechnol (2004) 1.81
SNP identification in unamplified human genomic DNA with gold nanoparticle probes. Nucleic Acids Res (2005) 1.22
Single-nucleotide polymorphism genotyping by nanoparticle-enhanced surface plasmon resonance imaging measurements of surface ligation reactions. Anal Chem (2006) 1.20
Single-nucleotide polymorphism genotyping on optical thin-film biosensor chips. Proc Natl Acad Sci U S A (2003) 1.16
Homogeneous point mutation detection by quantum dot-mediated two-color fluorescence coincidence analysis. Nucleic Acids Res (2006) 1.03
Loss of heterozygosity analyzed by single nucleotide polymorphism array in cancer. World J Gastroenterol (2005) 1.02
Nanoparticle diffraction gratings for DNA detection on photopatterned glass substrates. Biointerphases (2008) 0.97
High sensitivity EndoV mutation scanning through real-time ligase proofreading. Nucleic Acids Res (2004) 0.94
Complete gene scanning by temperature gradient capillary electrophoresis using the cystic fibrosis transmembrane conductance regulator gene as a model. J Mol Diagn (2005) 0.92
Real-Time PCR: Revolutionizing Detection and Expression Analysis of Genes. Curr Genomics (2007) 0.84
Straightforward detection of SNPs in double-stranded DNA by using exonuclease III/nuclease S1/PNA system. Nucleic Acids Res (2004) 0.83
Single-nucleotide polymorphism (SNP) genotyping using cationic conjugated polymers in homogeneous solution. Nat Protoc (2009) 0.83
A FRET-based analysis of SNPs without fluorescent probes. Nucleic Acids Res (2004) 0.82
Fluorescent detection and isolation of DNA variants using stabilized RecA-coated oligonucleotides. Genome Res (2003) 0.81
Clamping down on weak terminal base pairs: oligonucleotides with molecular caps as fidelity-enhancing elements at the 5'- and 3'-terminal residues. Nucleic Acids Res (2004) 0.81
Low density DNA microarray for detection of most frequent TP53 missense point mutations. BMC Biotechnol (2005) 0.80
Susceptibility of XPD and RAD51 genetic variants to carcinoma of urinary bladder in North Indian population. DNA Cell Biol (2011) 0.78
Genetic risk of lung cancer associated with a single nucleotide polymorphism from EXO1: a meta analysis. Int J Clin Exp Med (2015) 0.78
Specific mutation screening of TP53 gene by low-density DNA microarray. Nanotechnol Sci Appl (2009) 0.75
A universal probe design for colorimetric detection of single-nucleotide variation with visible readout and high specificity. Sci Rep (2016) 0.75
Rapid Genotyping of MSTN Gene Polymorphism Using High-resolution Melting for Association Study in Rabbits. Asian-Australas J Anim Sci (2013) 0.75
Correlation between SNP genotypes and periodontitis in Japanese type II diabetic patients: a preliminary study. Odontology (2014) 0.75
Initial sequencing and analysis of the human genome. Nature (2001) 212.86
The sequence of the human genome. Science (2001) 101.55
A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature (2001) 42.18
Real time quantitative PCR. Genome Res (1996) 35.79
The hitch-hiking effect of a favourable gene. Genet Res (1974) 34.74
Prospects for whole-genome linkage disequilibrium mapping of common disease genes. Nat Genet (1999) 25.93
Use of unlinked genetic markers to detect population stratification in association studies. Am J Hum Genet (1999) 23.67
High-resolution haplotype structure in the human genome. Nat Genet (2001) 20.51
The effect of deleterious mutations on neutral molecular variation. Genetics (1993) 20.07
Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. Science (1998) 18.23
Searching for genetic determinants in the new millennium. Nature (2000) 17.50
Linkage disequilibrium in the human genome. Nature (2001) 17.24
Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis. Nat Genet (1999) 17.09
The effect of linkage on limits to artificial selection. Genet Res (1966) 16.21
Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21. Science (2001) 15.54
The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med (1997) 13.96
Comprehensive human genome amplification using multiple displacement amplification. Proc Natl Acad Sci U S A (2002) 13.58
Using oligonucleotide probe arrays to access genetic diversity. Biotechniques (1995) 12.18
The evolutionary advantage of recombination. Genetics (1974) 11.65
Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet (2001) 11.12
Digital PCR. Proc Natl Acad Sci U S A (1999) 10.54
Mutation detection and single-molecule counting using isothermal rolling-circle amplification. Nat Genet (1998) 9.84
Trimming, weighting, and grouping SNPs in human case-control association studies. Genome Res (2001) 9.41
Multicolor molecular beacons for allele discrimination. Nat Biotechnol (1998) 9.40
Whole genome amplification from a single cell: implications for genetic analysis. Proc Natl Acad Sci U S A (1992) 9.15
Degenerate oligonucleotide-primed PCR: general amplification of target DNA by a single degenerate primer. Genomics (1992) 9.06
Haplotype variation and linkage disequilibrium in 313 human genes. Science (2001) 8.52
Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet (2000) 8.33
Solid phase DNA minisequencing by an enzymatic luminometric inorganic pyrophosphate detection assay. Anal Biochem (1993) 7.71
Variation is the spice of life. Nat Genet (2001) 7.62
A ligase-mediated gene detection technique. Science (1988) 7.61
The p53 pathway. J Pathol (1999) 6.79
Detection of numerous Y chromosome biallelic polymorphisms by denaturing high-performance liquid chromatography. Genome Res (1997) 6.73
Reactivity of cytosine and thymine in single-base-pair mismatches with hydroxylamine and osmium tetroxide and its application to the study of mutations. Proc Natl Acad Sci U S A (1988) 6.46
Quantum-dot-tagged microbeads for multiplexed optical coding of biomolecules. Nat Biotechnol (2001) 6.30
Padlock probes: circularizing oligonucleotides for localized DNA detection. Science (1994) 6.17
Disruption of p53 in human cancer cells alters the responses to therapeutic agents. J Clin Invest (1999) 6.13
The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat Genet (1995) 5.83
Low nucleotide diversity in man. Genetics (1991) 5.83
Methods for genotyping single nucleotide polymorphisms. Annu Rev Genomics Hum Genet (2001) 5.79
Lack of polymorphism on the Drosophila fourth chromosome resulting from selection. Genetics (1991) 5.77
Juxtaposed regions of extensive and minimal linkage disequilibrium in human Xq25 and Xq28. Nat Genet (2000) 5.65
Chip-based genotyping by mass spectrometry. Proc Natl Acad Sci U S A (1999) 5.63
Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science (1994) 5.54
Conformation-sensitive gel electrophoresis for rapid detection of single-base differences in double-stranded PCR products and DNA fragments: evidence for solvent-induced bends in DNA heteroduplexes. Proc Natl Acad Sci U S A (1993) 5.47
Population genetics--making sense out of sequence. Nat Genet (1999) 5.28
Accessing genetic variation: genotyping single nucleotide polymorphisms. Nat Rev Genet (2001) 5.00
The power of genomic control. Am J Hum Genet (2000) 4.99
Genetic disease detection and DNA amplification using cloned thermostable ligase. Proc Natl Acad Sci U S A (1991) 4.89
Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet (1997) 4.86
Molecular population genetics of the distal portion of the X chromosome in Drosophila: evidence for genetic hitchhiking of the yellow-achaete region. Genetics (1991) 4.85
Direct fluorescence analysis of genetic polymorphisms by hybridization with oligonucleotide arrays on glass supports. Nucleic Acids Res (1994) 4.77
PCR-SSCP: a simple and sensitive method for detection of mutations in the genomic DNA. PCR Methods Appl (1991) 4.58
Signal amplification of padlock probes by rolling circle replication. Nucleic Acids Res (1998) 4.52
Thermodynamic basis of the enhanced specificity of structured DNA probes. Proc Natl Acad Sci U S A (1999) 4.46
Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet (1996) 4.36
Linkage disequilibrium: what history has to tell us. Trends Genet (2002) 4.33
High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Proc Natl Acad Sci U S A (2001) 4.31
Detection of heterozygous mutations in BRCA1 using high density oligonucleotide arrays and two-colour fluorescence analysis. Nat Genet (1996) 4.19
Islands of linkage disequilibrium. Nat Genet (2001) 4.08
The genetically isolated populations of Finland and sardinia may not be a panacea for linkage disequilibrium mapping of common disease genes. Nat Genet (2000) 3.92
Pharmacological rescue of mutant p53 conformation and function. Science (1999) 3.91
Pharmacogenetics and the practice of medicine. Nature (2000) 3.68
Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products. Oncogene (1990) 3.65
Background selection and patterns of genetic diversity in Drosophila melanogaster. Genet Res (1996) 3.60
SNPing away at complex diseases: analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease. Am J Hum Genet (2000) 3.58
Whole genome amplification using a degenerate oligonucleotide primer allows hundreds of genotypes to be performed on less than one nanogram of genomic DNA. Proc Natl Acad Sci U S A (1996) 3.15
Genetic instability occurs in the majority of young patients with colorectal cancer. Nat Med (1995) 3.07
Multiplex detection of single-nucleotide variations using molecular beacons. Genet Anal (1999) 2.99
A primer-guided nucleotide incorporation assay in the genotyping of apolipoprotein E. Genomics (1990) 2.95
A system for specific, high-throughput genotyping by allele-specific primer extension on microarrays. Genome Res (2000) 2.94
The relative power of SNPs and haplotype as genetic markers for association tests. Pharmacogenomics (2001) 2.83
The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Nat Genet (1996) 2.82
Genetic epidemiology of single-nucleotide polymorphisms. Proc Natl Acad Sci U S A (1999) 2.81
Complete genomic screen in Parkinson disease: evidence for multiple genes. JAMA (2001) 2.79
Screening for mutations by enzyme mismatch cleavage with T4 endonuclease VII. Proc Natl Acad Sci U S A (1995) 2.78
Gene mapping in the 20th and 21st centuries: statistical methods, data analysis, and experimental design. Hum Biol (2000) 2.65
Evidence that genetic instability occurs at an early stage of colorectal tumorigenesis. Cancer Res (2001) 2.65
Improving the fidelity of Thermus thermophilus DNA ligase. Nucleic Acids Res (1996) 2.58
The value of isolated populations. Nat Genet (2001) 2.51
Universal DNA microarray method for multiplex detection of low abundance point mutations. J Mol Biol (1999) 2.47
Single-nucleotide polymorphism identification assays using a thermostable DNA polymerase and delayed extraction MALDI-TOF mass spectrometry. Genome Res (1997) 2.37
Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease. JAMA (2001) 2.36
Rapid determination of single base mismatch mutations in DNA hybrids by direct electric field control. Proc Natl Acad Sci U S A (1997) 2.31
Multiplexed single nucleotide polymorphism genotyping by oligonucleotide ligation and flow cytometry. Cytometry (2000) 2.30
The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women. Am J Hum Genet (1997) 2.28
High frequency of BRCA1 and BRCA2 germline mutations in Ashkenazi Jewish ovarian cancer patients, regardless of family history. Gynecol Oncol (1997) 2.25
Single base pair mutation analysis by PNA directed PCR clamping. Nucleic Acids Res (1993) 2.20
Robust and accurate single nucleotide polymorphism genotyping by dynamic allele-specific hybridization (DASH): design criteria and assay validation. Genome Res (2001) 2.19
The correlation between intron length and recombination in drosophila. Dynamic equilibrium between mutational and selective forces. Genetics (2000) 2.11
Rapid p53 sequence analysis in primary lung cancer using an oligonucleotide probe array. Proc Natl Acad Sci U S A (1999) 2.08
BADGE, Beads Array for the Detection of Gene Expression, a high-throughput diagnostic bioassay. Genome Res (2001) 2.05
A microsphere-based assay for multiplexed single nucleotide polymorphism analysis using single base chain extension. Genome Res (2000) 2.00
Amplification of target-specific, ligation-dependent circular probe. Gene (1998) 1.96
From gels to chips: "minisequencing" primer extension for analysis of point mutations and single nucleotide polymorphisms. Hum Mutat (1999) 1.91
Biochemical properties of a high fidelity DNA ligase from Thermus species AK16D. Nucleic Acids Res (1999) 1.89
Allele frequency distributions in pooled DNA samples: applications to mapping complex disease genes. Genome Res (1998) 1.81
Fidelity of DNA ligation: a novel experimental approach based on the polymerisation of libraries of oligonucleotides. Nucleic Acids Res (1998) 1.80
Genotyping by mass spectrometric analysis of short DNA fragments. Nat Biotechnol (1998) 1.76
Mechanisms underlying losses of heterozygosity in human colorectal cancers. Proc Natl Acad Sci U S A (2001) 1.68
Pegaptanib for neovascular age-related macular degeneration. N Engl J Med (2004) 12.01
Inferring the history of speciation from multilocus DNA sequence data: the case of Drosophila pseudoobscura and close relatives. Mol Biol Evol (2002) 3.84
Relationship of gene expression and chromosomal abnormalities in colorectal cancer. Cancer Res (2006) 3.32
CpG island methylator phenotype associates with low-degree chromosomal abnormalities in colorectal cancer. Clin Cancer Res (2008) 2.65
Interactions between natural selection, recombination and gene density in the genes of Drosophila. Genetics (2002) 2.20
Association of survival and disease progression with chromosomal instability: a genomic exploration of colorectal cancer. Proc Natl Acad Sci U S A (2009) 1.72
c-Met gene amplification is associated with advanced stage colorectal cancer and liver metastases. Cancer Lett (2008) 1.71
The presence of p53 mutations in human osteosarcomas correlates with high levels of genomic instability. Proc Natl Acad Sci U S A (2003) 1.69
High-throughput selection, enumeration, electrokinetic manipulation, and molecular profiling of low-abundance circulating tumor cells using a microfluidic system. Anal Chem (2011) 1.62
Expression of L1-CAM and ADAM10 in human colon cancer cells induces metastasis. Cancer Res (2007) 1.46
Emerging paradigms in cancer genetics: some important findings from high-density single nucleotide polymorphism array studies. Cancer Res (2009) 1.34
KRAS mutation and microsatellite instability: two genetic markers of early tumor development that influence the prognosis of colorectal cancer. Ann Surg Oncol (2009) 1.26
HER 2/neu expression and gene amplification in colon cancer. Int J Cancer (2003) 1.26
Polymerase chain reaction/ligase detection reaction/hybridization assays using flow-through microfluidic devices for the detection of low-abundant DNA point mutations. Biosens Bioelectron (2006) 1.26
Ligase detection reaction/hybridization assays using three-dimensional microfluidic networks for the detection of low-abundant DNA point mutations. Anal Chem (2005) 1.24
Capillary and microelectrophoretic separations of ligase detection reaction products produced from low-abundant point mutations in genomic DNA. Electrophoresis (2004) 1.23
Fine-scale crossover rate heterogeneity in Drosophila pseudoobscura. J Mol Evol (2006) 1.22
Approaching real-time molecular diagnostics: single-pair fluorescence resonance energy transfer (spFRET) detection for the analysis of low abundant point mutations in K-ras oncogenes. J Am Chem Soc (2003) 1.15
GROalpha is highly expressed in adenocarcinoma of the colon and down-regulates fibulin-1. Clin Cancer Res (2006) 1.12
The signatures of autozygosity among patients with colorectal cancer. Cancer Res (2008) 1.10
A randomized phase 2 study of erlotinib alone and in combination with bortezomib in previously treated advanced non-small cell lung cancer. J Thorac Oncol (2009) 1.08
Genome-wide autozygosity mapping in human populations. Genet Epidemiol (2009) 1.07
Multiplexed identification of blood-borne bacterial pathogens by use of a novel 16S rRNA gene PCR-ligase detection reaction-capillary electrophoresis assay. J Clin Microbiol (2007) 1.07
Estimation of isolation times of the island species in the Drosophila simulans complex from multilocus DNA sequence data. PLoS One (2008) 1.06
Microarrays assembled in microfluidic chips fabricated from poly(methyl methacrylate) for the detection of low-abundant DNA mutations. Anal Chem (2003) 1.02
Multiplexed profiling of candidate genes for CpG island methylation status using a flexible PCR/LDR/Universal Array assay. Genome Res (2005) 1.02
Molecular profiling of colon tumors: the search for clinically relevant biomarkers of progression, prognosis, therapeutics, and predisposition. Ann Surg Oncol (2011) 1.02
Mutational analysis of endonuclease V from Thermotoga maritima. Biochemistry (2002) 1.02
Rapid and sensitive p53 alteration analysis in biopsies from lung cancer patients using a functional assay and a universal oligonucleotide array: a prospective study. Clin Cancer Res (2004) 0.98
High sensitivity EndoV mutation scanning through real-time ligase proofreading. Nucleic Acids Res (2004) 0.94
Gene dysregulations driven by somatic copy number aberrations-biological and clinical implications in colon tumors: a paper from the 2009 William Beaumont Hospital Symposium on Molecular Pathology. J Mol Diagn (2010) 0.93
An endonuclease/ligase based mutation scanning method especially suited for analysis of neoplastic tissue. Oncogene (2002) 0.93
MAGI1 copy number variation in bipolar affective disorder and schizophrenia. Biol Psychiatry (2012) 0.92
MDM2 gene amplification is correlated to tumor progression but not to the presence of SNP309 or TP53 mutational status in primary colorectal cancers. Mol Cancer Res (2008) 0.91
Harmonized microarray/mutation scanning analysis of TP53 mutations in undissected colorectal tumors. Hum Mutat (2004) 0.91
Applications of the universal DNA microarray in molecular medicine. Methods Mol Med (2005) 0.91
Fabrication of DNA microarrays onto poly(methyl methacrylate) with ultraviolet patterning and microfluidics for the detection of low-abundant point mutations. Anal Biochem (2005) 0.91
Detection of the BRAF V600E mutation in melanocytic lesions using the ligase detection reaction. J Cutan Pathol (2005) 0.90
Prespecified candidate biomarkers identify follicular lymphoma patients who achieved longer progression-free survival with bortezomib-rituximab versus rituximab. Clin Cancer Res (2013) 0.89
Unique ligation properties of eukaryotic NAD+-dependent DNA ligase from Melanoplus sanguinipes entomopoxvirus. Biochim Biophys Acta (2004) 0.89
Allosteric alpha-7 nicotinic receptor modulation and P50 sensory gating in schizophrenia: a proof-of-mechanism study. Neuropharmacology (2012) 0.83
Serial processing of biological reactions using flow-through microfluidic devices: coupled PCR/LDR for the detection of low-abundant DNA point mutations. Analyst (2007) 0.83
Fully integrated thermoplastic genosensor for the highly sensitive detection and identification of multi-drug-resistant tuberculosis. Angew Chem Int Ed Engl (2012) 0.83
Modular microfluidic system fabricated in thermoplastics for the strain-specific detection of bacterial pathogens. Lab Chip (2012) 0.83
Ligase detection reaction for the analysis of point mutations using free-solution conjugate electrophoresis in a polymer microfluidic device. Electrophoresis (2008) 0.83
Loss of imprinting and marked gene elevation are 2 forms of aberrant IGF2 expression in colorectal cancer. Int J Cancer (2010) 0.83
Variability on the dot chromosome in the Drosophila simulans clade. Genetica (2003) 0.82
Genetic variants in germline TP53 and MDM2 SNP309 are not associated with early onset colorectal cancer. J Surg Oncol (2008) 0.82
PCR/LDR/universal array platforms for the diagnosis of infectious disease. Methods Mol Biol (2010) 0.82
A new test for selection applied to codon usage in Drosophila simulans and D. mauritiana. J Mol Evol (2008) 0.80
Improved testing for microsatellite instability in colorectal cancer using a simplified 3-marker assay. Ann Surg Oncol (2010) 0.79
Switching base preferences of mismatch cleavage in endonuclease V: an improved method for scanning point mutations. Nucleic Acids Res (2006) 0.79
High incidence of LRAT promoter hypermethylation in colorectal cancer correlates with tumor stage. Med Oncol (2014) 0.79
SCN9A Variants May be Implicated in Neuropathic Pain Associated With Diabetic Peripheral Neuropathy and Pain Severity. Clin J Pain (2015) 0.78
Robust physical methods that enrich genomic regions identical by descent for linkage studies: confirmation of a locus for osteogenesis imperfecta. BMC Genet (2009) 0.77
Large-scale candidate gene study to identify genetic risk factors predictive of paliperidone treatment response in patients with schizophrenia. Pharmacogenet Genomics (2015) 0.77
Harnessing asymmetrical substrate recognition by thermostable EndoV to achieve balanced linear amplification in multiplexed SNP typing. Biochem Cell Biol (2006) 0.76
SULT4A1 haplotype: conflicting results on its role as a biomarker of antipsychotic response. Pharmacogenomics (2014) 0.75
Hidden evolution: progress and limitations in detecting multifarious natural selection. Genetica (2002) 0.75